Transcranial magnetic stimulation request form Form

Chat with GenHealth to automate any policy or prior auth task.


Transcranial magnetic stimulation request form

Indications

(1) Is the requested option Initial treatment request? 
(2) Is the requested option Repeat course of treatment request Date of request: MEMBER INFORMATION Member name: Member ID number: Date of birth: Age: Date of request: PROVIDER INFORMATION? 
(3) Is the requested option In network? 
(4) Is the requested option Out of network (please provide clinical rationale below) NPI/TIN number: Outpatient provider information (if applicable and if different than above)? 
(5) Is the requested option Member is 18 years or older and? 

YesNoN/A
YesNoN/A
YesNoN/A

Sign up to see the rest of the questions

Unlock the remaining questions and the full coverage workflow.

Sign up for free
Effective Date

NA

Last Reviewed

NA

Original Document

  Reference



Transcranial Magnetic Stimulation (TMS) Request Form Submit to: Behavioral Health Utilization Management Fax: 1-877-234-4273 For assistance, please call: 1-855-301-5512 Please complete all sections of this form as thoroughly as possible. You may also include any additional clinical information pertinent to this authorization request. □ Initial treatment request
□ Repeat course of treatment request Date of request: MEMBER INFORMATION Member name: Member ID number: Date of birth: Age: Date of request: PROVIDER INFORMATION Requesting TMS clinician or facility: Address: Phone: Fax: □ In network □ Out of network (please provide clinical rationale below)
NPI/TIN number: Outpatient provider information (if applicable and if different than above) Psychiatrist name: Phone and fax numbers: Therapist name: Phone and fax numbers: INITIAL TREATMENT REQUIREMENTS □ Member is 18 years or older and □ Member is not pregnant or breast feeding and □ Member has a confirmed diagnosis of severe major depressive disorder, single or recurrent and □ Resistance to prior treatment (select one or more of the following and provide documentation of unsuccessful trials): □ Inability to tolerate psychopharmacologic agents as evidenced by four trials of psychopharmacologic agents from at least two different agent classes, at or above the minimum effective dose and duration (at least one of which is in the antidepressant class), with distinct side effects, or □ Inability to tolerate psychopharmacologic agents as evidenced by three different antidepressants from at least two different agent classes, plus one with an augmenting agent. Augmentation therapy: when one or more drugs are not antidepressants, but are added to increase the effect of an antidepressant drug for adults with major depressive disorder (e.g., adding Buspirone), or □ Antidepressants contradicted (e.g., medical condition or serious adverse effects), or □ History of response to TMS in a previous depressive episode or □ Currently receiving electroconvulsive therapy (ECT) and TMS is considered a less invasive treatment option or □ Currently considering ECT and TMS may be considered as a less invasive treatment option And □ Trial of evidence-based psychotherapy known to be effective in the treatment of major depressive disorder without significant improvement in symptoms and documented as such by standardized rating scales that reliably measure depressive symptoms (GDS, PHQ-9, BDI, HAM-D, MADRS, QIDS, or IDS-SR) Page 1 of 2

Transcranial Magnetic Stimulation (TMS) Request Form INITIAL TREATMENT REQUIREMENTS And there are no known potential contraindications. Please mark if the member has any of the below: □ Seizure disorder or any history of seizures (except those induced by ECT or isolated febrile seizures in infancy without subsequent treatment or recurrence) □ Presence of acute or chronic psychotic symptoms □ Known nonadherence with previous treatment for depression □ Current or known substance use at time of referral or start of TMS treatments □ Neurological conditions that include epilepsy, cerebrovascular disease, dementia, increased intracranial pressure, history of repetitive or severe head trauma, or primary or secondary tumors in the central nervous system □ Presence of an implanted magnetic-sensitive medical device located less than or equal to 30 cm from the TMS magnetic coil or other implanted metal items including, but not limited to, a cochlear implant, implanted cardiac defibrillator (ICD), pacemaker, vagus nerve stimulation (VNS), or metal aneurysm clips, coils, staples, or stents REPEAT COURSE OF TREATMENT REQUIREMENTS Date of initial treatment, if known: □ Member continues to meet the guidelines for initial course of treatment and □ Member is experiencing continued depressive symptoms and □ Member has responded to prior treatments, as evidenced by a greater than 50 percent improvement in standardized rating scale measurements for depressive symptoms (note rating below): GDS: PHQ-9:
BDI: HAM-D: MADRS: QIDS: IDS-SR: ___ TREATMENT PLAN REQUIREMENTS for both initial and retreatment (choose the requested number of units) □ 36 standard repetitive treatments □ 44 deep treatments One time per day, five days per week for six weeks One time per day, five days per week for four weeks Six final sessions tapered over three weeks 24 final sessions with one time per day, two days per week for 12 weeks Provider or requestor signature: Date: ACDE1787975 Page 2 of 2 SIGN

Book a walkthrough

Walk through this policy with us

Review how this policy can be converted into cited criteria, prior authorization checks, and operational automation.